Trial
NCT01602198
Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
The Cleveland Clinic
Collaborators
—
Condition
Mild Cognitive Disorder
Intervention
Exelon [rivastigmine] transdermal patch
Why stopped
Study revised to use a different study medication and patient population.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-28